Literature DB >> 8382876

Randomized controlled trial of acyclovir for the prevention of cytomegalovirus infection and disease in liver transplant recipients.

F Saliba1, D Eyraud, D Samuel, M F David, J L Arulnaden, E Dussaix, D Mathieu, H Bismuth.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1993        PMID： 8382876

Source DB:  PubMed          Journal:  Transplant Proc        ISSN： 0041-1345            Impact factor:   1.066


× No keyword cloud information.
  6 in total

Review 1.  Infections in solid-organ transplant recipients.

Authors:  R Patel; C V Paya
Journal:  Clin Microbiol Rev       Date:  1997-01       Impact factor: 26.132

Review 2.  New strategies for prevention and therapy of cytomegalovirus infection and disease in solid-organ transplant recipients.

Authors:  I G Sia; R Patel
Journal:  Clin Microbiol Rev       Date:  2000-01       Impact factor: 26.132

Review 3.  Current management strategies for the prevention and treatment of cytomegalovirus infection in pediatric transplant recipients.

Authors:  Javier Bueno; Carmen Ramil; Michael Green
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

Review 4.  Pre-emptive treatment for cytomegalovirus viraemia to prevent cytomegalovirus disease in solid organ transplant recipients.

Authors:  Daniel S Owers; Angela C Webster; Giovanni F M Strippoli; Kathy Kable; Elisabeth M Hodson
Journal:  Cochrane Database Syst Rev       Date:  2013-02-28

5.  Atypical oral presentation of herpes simplex virus infection in a patient after orthotopic liver transplantation.

Authors:  E M Burke; D L Karp; T C Wu; R L Corio
Journal:  Eur Arch Otorhinolaryngol       Date:  1994       Impact factor: 2.503

Review 6.  Aciclovir. A reappraisal of its antiviral activity, pharmacokinetic properties and therapeutic efficacy.

Authors:  A J Wagstaff; D Faulds; K L Goa
Journal:  Drugs       Date:  1994-01       Impact factor: 9.546
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.